Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-021372
Filing Date
2025-06-26
Accepted
2025-06-26 17:47:53
Documents
1
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4167
  Complete submission text file 0001437749-25-021372.txt   5723
Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Schimmelpennink Evert B. (Reporting) CIK: 0001713795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42001 | Film No.: 251081554

Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Issuer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)